Mode
Text Size
Log in / Sign up

Anti-interferon-gamma autoantibody-associated immunodeficiency may explain severe melioidosis and necrotic skin lesionsNew immune condition may explain severe cases of melioidosis infection

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider melioidosis in patients with necrotic skin lesions after freshwater exposure; investigate anti-interferon-gamma autoantibodies if severity is unexplained.

This case report and literature review explores the clinical presentation of melioidosis in a 66-year-old woman from northeast Thailand. The patient presented with a necrotic skin lesion and fever. Laboratory findings confirmed B. pseudomallei, which was resistant to ceftazidime but susceptible to imipenem and trimethoprim/sulfamethoxazole. The patient showed clinical improvement and resolution of fever and skin lesions following treatment with meropenem. Imaging at 3 months showed complete resolution.

The authors synthesize findings from a literature review of 6 previously published cases of melioidosis involving an eschar or eschar-like necrotic lesion. The report highlights the potential role of anti-interferon-gamma autoantibody-associated immunodeficiency in causing severe clinical manifestations of melioidosis.

A significant limitation of this evidence is the small sample size, consisting of only one case report and a review of 6 cases. Clinical implications suggest that melioidosis should be suspected in patients with rapidly progressive visceral abscesses and necrotic skin lesions following heavy freshwater exposure. Unexplained severity in these cases should prompt evaluation for anti-interferon-gamma autoantibody-associated immunodeficiency.

How this fits prior evidence

This case report and literature review addresses a gap in understanding the severity of melioidosis. It specifically explores the role of anti-interferon-gamma autoantibody-associated immunodeficiency in severe presentations. This adds context to the management of severe infections, such as the case of chorioamnionitis and septicemia involving Hafnia alvei, by highlighting specific underlying immunodeficiencies that may contribute to clinical severity in endemic regions.

Imagine catching a common soil-borne infection that suddenly turns life-threatening. For a 66-year-old woman in Thailand, a melioidosis infection caused severe skin lesions and internal issues. While the bacteria were resistant to some common antibiotics, she responded well to others, eventually seeing her fever and skin lesions clear up.

Doctors looked closer at why her case was so severe. They found a specific immune deficiency involving anti-interferon-gamma autoantibodies. This condition can make it harder for the body to fight off certain infections. In her case, it likely played a role in the severity of the illness.

Because this is a rare finding, the evidence comes from a single case and a small review of six other similar patients. While it highlights a specific immune link, the small sample size means we are still learning about how often this happens. It serves as a reminder for doctors to look for these specific immune markers when patients have unusually severe infections after being near floodwaters.

What this means for you:
A specific immune deficiency involving autoantibodies may explain why some melioidosis infections become severe.

Common questions

What is melioidosis and why is it serious?

Melioidosis is an infection caused by the bacteria B. pseudomallei. It can cause serious issues like fever and skin lesions. In some cases, it becomes very severe, especially in people with certain immune deficiencies. Doctors suggest looking for it in people with severe internal abscesses or skin issues after they have been near floodwaters or heavy freshwater.

What caused the severe symptoms in this patient?

The patient had a specific immune deficiency called anti-interferon-gamma autoantibody-associated adult-onset immunodeficiency. This condition involves the body producing antibodies against its own proteins, which can make it harder to fight off infections like melioidosis.

Which medications were used to treat the infection?

The patient was treated with several antibiotics, including meropenem, trimethoprim/sulfamethoxazole, ceftazidime, and imipenem. While the bacteria were resistant to ceftazidime, the patient showed a good clinical response to meropenem, which helped resolve her fever and skin lesions.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
Melioidosis, caused by the environmental saprophyte Burkholderia pseudomallei, is acquired from soil and surface water and rises sharply in incidence after heavy rainfall and flooding—something that extreme-weather trends under climate change are expected to make more frequent and more widespread. The disease presents with a broad clinical spectrum, but eschars or ecthyma gangrenosum-like necrotic skin lesions are very rarely reported and may be mistaken for scrub typhus in coendemic regions. A 66-year-old woman from northeast Thailand with no known comorbidity presented with fever and chest pain 1 week after walking barefoot through floodwater. Contrast-enhanced computed tomography demonstrated mediastinal necrotic lymphadenitis and hepatosplenic microabscesses. Despite broad-spectrum β-lactam therapy, she remained febrile and, on illness day 8, developed a painful subcutaneous nodule that evolved within 2 days into a dark, eschar-like lesion. Pus culture grew B. pseudomallei that was resistant to ceftazidime and susceptible to imipenem and trimethoprim/sulfamethoxazole. Her fever and skin lesion resolved with meropenem. Because the disease was unusually aggressive and accompanied by recurrent, self-limiting panniculitis-like episodes, she was evaluated for adult-onset immunodeficiency and anti-interferon-γ autoantibodies were detected. She completed 1 month of meropenem followed by trimethoprim/sulfamethoxazole eradication therapy, and imaging at 3 months showed complete resolution. A structured review identified only six previously published patients with an eschar or eschar-like necrotic lesion in culture-confirmed melioidosis; the majority, as in our patient, had disseminated disease, and almost all had a documented soil or freshwater exposure. Melioidosis should be considered in patients with rapidly progressive visceral abscesses and necrotic skin lesions in the weeks after flooding or other heavy freshwater exposure in endemic regions, and unexplained severity should prompt evaluation for anti-interferon-γ autoantibody-associated immunodeficiency together with confirmation of unusual resistance phenotypes. As flooding becomes more frequent, clinical awareness and simple protective measures during and after floods are likely to be increasingly important.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.